Clinical Trial Update: Low-dose IL-2 Treatment on Behcet's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating low-dose IL-2 for Behcet's Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behcet Disease

Drugs mentioned

• low-dose IL-2 (interleukin-2)

Snippet

Sponsor: HeJing | Conditions: Behcet's Disease | Phase 2 | Status: COMPLETED